drugset / Trial / NCT00540631

Multicenter Trial of Immunotherapy With House Dust Mite Allergoid

NCT00540631 ↗

Phase 3 Completed 108 enrolled Allergopharma GmbH & Co. KG
RandomizedParallel-groupDouble-blindTreatment

Summary

Multicenter Immunotherapy House Dust Mite Allergoid

Timeline

Start
2007-10
Primary completion
2010-08
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Acaroid Protein / enzyme biologic 0.6 ml Subcutaneous
Subject Acaroid Protein / enzyme biologic 6000 unknown Subcutaneous

Indications